Although both full-length BCAN and BCAN HA binding domain (HABD) can promote invasion of glioma cells in non-neurogenic ECM, it seems that only HABD remains functional, promoting the invasion in brain ECM [159,214]. The gene discussed is BCAN; the disease is glioma.